Outcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
14-Aug-2026
Download PDF
Orchid Pharma
Outcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.